NEWS

April 1, 2020

COVID-19 DSI Operation Update

While this has opened up many new avenues in sharing information, We want to reassure you of DSI’s service resilience during this time. In fact, as you may be aware, we have been supporting CMC for our clients' programs VIRTUALLY FOR OVER 14 YEARS.
December 19, 2019

2020 J.P. Morgan Health Care Investor Conference

A scientific review of the pertinent development data provides the necessary information to assure that informed decisions are made regarding the potential in-licensing of a development compound. By highlighting perceived risks and resource implications, the examination provides assurance that a given compound meets the requisite technical and quality elements. In advance of Biotech Showcase and the JP Morgan Healthcare Conferences next month, we are providing our complementary Drug Product Due Diligence Checklist. Send us a message if you would like a copy.
September 20, 2019

DSI Expert James Mencel to present at AMRI Symposium reACTION 2019

Drug Substance Development Expert, Dr. James Mencel, will be presenting “Expedited Filings and their CMC Implications: Considerations toward Better Planning”, sponsored by AMRI, a global contract research and manufacturing organization. Conference sessions will occur at AMRI’s Corporate Headquarters.
August 15, 2019

DSI to Showcase Progressive Drug Development Strategies and Products at the 2019 Biotech Week Boston

DSI will be attending Biotech Week Boston 2019, find us at BioPharm America on September 09-12th. Biotech Week Boston is dedicated to accelerating the business of biotechnology through new ideas, science, technology and partnerships to make a positive impact on patient health.
May 10, 2019

DSI announces participation in the BIO One-on-One Partnering™ at the 2019 BIO International Convention

I have never been so simultaneously energized and exhausted than during BIO Week. From the moment you arrive in the city, you’ll experience morning to evening activity. From keynote speeches with luminaries, to panels and partnering meetings with pharma CEOs, to a number of parties ranging from circus performers to whiskey tastings, to yes… Cheesesteak options!
April 10, 2019

DSI Announces Participation in the 2019 CPhI North America Conference

DSI, the leading Chemistry, Manufacturing and Controls consulting firm, today announced its participation in CPhI North America, the only Pharmaceutical Industry Event for the North American Supply Chain. This three-day event will be held on April 30-May 2, at the Lakeside Center at McCormick Place, Chicago, Illinois.